BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9794995)

  • 1. Radioprotectants: pharmacology and clinical applications of amifostine.
    Dorr RT
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):10-3. PubMed ID: 9794995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):3-21. PubMed ID: 10348255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future development of amifostine as a radioprotectant.
    Werner-Wasik M
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotective effects of amifostine.
    Wasserman T
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):89-94. PubMed ID: 10348266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of normal tissues from the cytotoxic effects of radiation therapy: focus on amifostine.
    Mehta MP
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):14-6. PubMed ID: 9794996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects.
    Peters GJ; van der Vijgh WJ
    Eur J Cancer; 1995; 31A Suppl 1():S1-7. PubMed ID: 7577093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amifostine modulation of bleomycin-induced lung injury in rodents.
    Nici L; Calabresi P
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):28-33. PubMed ID: 10348257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects.
    van der Vijgh WJ; Peters GJ
    Semin Oncol; 1994 Oct; 21(5 Suppl 11):2-7. PubMed ID: 7973774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of the cytoprotectant amifostine.
    Lindemann K
    Clin J Oncol Nurs; 1998 Jul; 2(3):101-4. PubMed ID: 10232150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amifostine in clinical oncology: current use and future applications.
    Koukourakis MI
    Anticancer Drugs; 2002 Mar; 13(3):181-209. PubMed ID: 11984063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amifostine: chemotherapeutic and radiotherapeutic protective effects.
    Santini V
    Expert Opin Pharmacother; 2001 Mar; 2(3):479-89. PubMed ID: 11336600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of amifostine.
    Shaw LM; Bonner H; Lieberman R
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):18-22. PubMed ID: 8783662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic protection by amifostine.
    DiPaola RS; Schuchter L
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):82-8. PubMed ID: 10348265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):72-81. PubMed ID: 10348264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review).
    Orditura M; De Vita F; Roscigno A; Infusino S; Auriemma A; Iodice P; Ciaramella F; Abbate G; Catalano G
    Oncol Rep; 1999; 6(6):1357-62. PubMed ID: 10523712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol).
    Capizzi RL
    Eur J Cancer; 1996; 32A Suppl 4():S5-16. PubMed ID: 8976816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amifostine and combined-modality therapeutic approaches.
    Mehta MP
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):95-101. PubMed ID: 10348267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amifostine: current and future applications in cytoprotection].
    Lenoble M
    Bull Cancer; 1996 Sep; 83(9):773-87. PubMed ID: 8952658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine: is there evidence of tumor protection?
    Koukourakis MI
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):18-30. PubMed ID: 14727237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.